Progenitor Biologics®, LLC, the manufacturer and distributor of the cutting-edge anti-aging skin care products, DefenAge® Skincare, is proud to announce the results of a new comprehensive clinical study of the line’s breakthrough ingredient Age-Repair Defensins®.
The defensin-based three-step system “globally improves the visual appearance of aging skin without irritation, dryness, or inflammation,” concludes the peer-review article published by the Journal of Drugs in Dermatology (JDD). Target-specific Age-Repair Defensins represents the latest generation of anti-aging technology and is the FIRST of a kind.
“The defensin skin care regimen resulted in statistically significant improvements in ALL five parameters in patients simultaneously including decreased visible fine and coarse wrinkles, pore size and visible pigmentation. Study participants also demonstrated improvement in skin’s oiliness, evenness, hydration and a number of other crucial skin’s qualities” shares the study’s principal investigator and correspondence author, Amy Forman Taub, MD. “DefenAge results in profound improvements in the visible health and beauty of the skin that are readily apparent to even the untrained eye.”
“The results showed that the defensin-containing trio of products offer most of the advantages of time-honored retinols as well as newer but widely used growth-factor containing cosmeceuticals, without irritation or inflammation, sun-sensitivity, or concerns about neoplasia of the treated skin,” adds the study’s co-investigator, Vivian Bucay, MD. “The observed clinical results put DefenAge Skincare into the best-in-class category without doubt, this is a landmark product.”